AI
Healthcare & Life Sciences
Ascendo Biotechnology, Inc
Ascendo Biotechnology, Inc is a Healthcare & Life Sciences startup, most recent round Series A.
series-a
series-a
Stage
About Ascendo Biotechnology, Inc
Ascendo Biotechnology, Inc is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences.
Ascendo Biotechnology is a Phase 1 clinical-stage company developing first-in-class innate immune-checkpoint therapies for cancer and autoimmune diseases, with its lead candidate ASD141 being an anti-CD11b antibody aimed at activating innate immunity in tumors resistant to PD-1/PD-L1 therapy.
Explore Ascendo Biotechnology, Inc's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.